Download PDF
1 / Pages

Other users also viewed these articles

The myth of the stigma of fatty liver: What does the evidence show? Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Nahum Méndez-Sánchez;
10.1016/j.aohep.2024.101535
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;
Ann Hepatol. 2024;29:
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis Mark Muthiah; Cheng Han Ng; Kai En Chan; Clarissa Elysia Fu; Wen Hui Lim; Darren Jun Hao Tan; Benjamin Nah; Gwyneth Kong; Jieling Xiao; Jie Ning Yong; Bryan Tan; Nicholas Syn; Jiong-Wei Wang; Nilofer Sayed; Eunice Tan; Nicholas WS Chew; Yock Young Dan; Mohammad Shadab Siddiqui; Arun J. Sanyal; Mazen Noureddin;
Ann Hepatol. 2023;28: